FDA Approves Sexual Desire Drug for Postmenopausal Women

By News Health
5 hours Ago

(MedPage Today) — The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
Flibanserin is a mixed 5-HT1A…

Source link : https://www.medpagetoday.com/obgyn/menopause/119031

Author :

Publish date : 2025-12-15 22:41:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Pyloroplasty With Electric Stimulation Treats Gastroparesis

Six Midlife Depressive Symptoms Tied to Dementia

Not Everyone Gets a Mortality Benefit From Reducing Saturated Fats, Study Says

Aspiring Neurosurgeon Died in Brown Campus Shooting

Smartphone-Delivered Digital Therapy Improved Anxiety Symptoms

Lung Cancer Screening Follow-Up Often Inadequate